NOV 02, 2016 06:00 AM PDT

Urine Toxicology Testing in Support of Pain Management

2 6 343

  • Medical Director of Toxicology and Esoteric Chemistry; Vanderbilt University Medical Center
      Jennifer M. Colby is an assistant professor in the department of Pathology, Microbiology, and Immunology and the medical director of Toxicology and Esoteric Chemistry at Vanderbilt University Medical Center. Jennifer earned her BS in Molecular and Cellular Biology from Vanderbilt University in 2007 and her PhD in Molecular Toxicology from the University of California Berkeley in 2012. She completed her postdoctoral training in clinical chemistry and toxicology at the University of California San Francisco in 2015. She is a member of SOFT, MATT, AACC, ACLPS, AACT, and IATDMCT. Her research interests include developing new applications for mass spectrometry in toxicology and laboratory medicine. When not in the lab Jennifer runs, competes in dressage, and enjoys exploring Tennessee with her Bouvier des Flandres.


    Chronic pain is a major problem in most countries. Specialized pain management physicians often see and treat patients with chronic pain, and one type of therapy that may be prescribed is an opioid analgesic.  Due to the abuse and addiction potential of opioids, patients on chronic opioid therapy are tested periodically for compliance using urine drug testing.  Urine toxicology results can help providers assess whether a patient has been taking their prescribed medications and abstaining from other medications, and can help preserve the trust between a patient and the health care team in sensitive situations.  This webinar will discuss urine drug testing as it relates to the management of chronic pain, and will cover frequently encountered drug/metabolite patterns that may influence the interpretation of compliance with opioid therapy.

    Show Resources
    Loading Comments...